The insomnia-mediated insulin resistance and metabolic syndrome could be correlated with the progression of NAFLD [241-243], possibly due to increased secretion of inflammatory cytokines such as IL-6 and TNF-α, leading to an abnormal increase in hepatic free fatty acids owing to adipocyte lipolysis [244-246]. Here, TNF is linked to insomnia.